Sign in

CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company

CRESCENT BIOPHARMA, INC.

Sign in to watch
Ticker
CBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
operating
Phone
617-430-5595
Business address
300 FIFTH AVENUE, WALTHAM, MA, 02451
Former names
GLYCOMIMETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$285,501
in 7 filings, $286K under 10b5-1 plans

Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
  2. McNeill Jonathan −$77K President and COO sold 3% of stake
  3. Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
  4. Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
  5. Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2014-01-15 BARRETT M JAMES Director Conversion · Series A-1 Preferred Stock −11,250,850 0
2014-01-15 BARRETT M JAMES Director Conversion · Series A-1 Preferred Stock −11,824,058 0
2014-01-15 NEW ENTERPRISE ASSOCIATES 13 LP 10% owner Conversion +3,580,877 3,580,877
2014-01-15 NEW ENTERPRISE ASSOCIATES 13 LP 10% owner Purchase +512,500 $8.00 $4.1M 4,093,377
2014-01-15 NEW ENTERPRISE ASSOCIATES 13 LP 10% owner Conversion · Series A-1 Preferred Stock −11,824,058 0
2014-01-15 NEW ENTERPRISE ASSOCIATES 10 L P 10% owner Conversion +3,407,283 3,994,258
2014-01-15 NEW ENTERPRISE ASSOCIATES 10 L P 10% owner Purchase +487,500 $8.00 $3.9M 4,481,758
2014-01-15 NEW ENTERPRISE ASSOCIATES 10 L P 10% owner Conversion · Series A-1 Preferred Stock −11,250,850 0
2014-01-09 TOP FRANKLIN H JR Director Grant or award · Stock Option (right to buy) +15,401 15,401
2014-01-09 Thackray Helen M. VP Clinical Development, CMO Grant or award · Stock Option (right to buy) +112,692 112,692
2014-01-09 Magnani John L. VP of Research, CSO Grant or award · Stock Option (right to buy) +169,038 169,038
2014-01-09 King Rachel K. President, CEO Grant or award · Stock Option (right to buy) +375,639 375,639
2014-01-09 HENOS MICHAEL A Director Grant or award · Stock Option (right to buy) +15,401 15,401
2014-01-09 Hahn Brian M. CFO Grant or award · Stock Option (right to buy) +37,564 37,564
2014-01-09 Gust William M. Director Grant or award · Stock Option (right to buy) +15,401 15,401
2014-01-09 Baldwin John J. Director Grant or award · Stock Option (right to buy) +15,401 15,401
2014-01-09 BARRETT M JAMES Director Grant or award · Stock Option (right to buy) +15,401 15,401

Page 20 of 20 · 397 trades